Product Information
Berotralstat is an anticancer drug that inhibits the activity of kinases, which are enzymes that play a critical role in the growth and proliferation of cancer cells. It has been shown to induce apoptosis, or programmed cell death, in various types of cancer cells. Berotralstat is an analog of caffeine and has been found to inhibit the activity of oxytocin receptors, which may contribute to its anti-tumor effects. This drug has also been shown to be effective against tumors in Chinese hamsters and has been detected in urine after administration. Berotralstat is a promising candidate for the treatment of various types of cancer due to its potent inhibitory effects on protein kinases.
Chemical properties
Technical inquiry about: Berotralstat
Please use instead the cart to request a quotation or an order